Welcome to the
Hepatitis B Foundation
Top Stories 
Eliminating Perinatal Transmission of Hepatitis B: More Than Just A Test
May 13 – Tackling and eliminating perinatal hepatitis B in the United States through the Viral Hepatitis Action Plan initiatives, vital partners and the implementation of provisions of the Affordable Care Act. Read more
Do Asian Patients Respond Better to Pegylated Interferon for Hepatitis B?
May 13 – Some Asian people with chronic hepatitis B treated with pegylated interferon may experience better outcomes on certain measures than Caucasians, though overall response rates are similar, according to a comparative analysis presented at the EASL International Liver Congress last month. Read more
Jennerex Granted FDA Orphan Drug Designation for Pexa-Vec in Hepatocellular Carcinoma (HCC)
May 13 – Jennerex's Pexa-Vec, an oncolytic immunotherapy designed to treat advanced HCC patients who have failed sorafenib, has received FDA orphan drug designation. Read more
Novel Tests Improve Diagnosis of Two Types of Liver Cancer
May 13 – New data from two clinical trials that were presented at the International Liver Congress 2013, demonstrated substantial improvements in the detection of both hepatocellular carcinoma (HCC) and cholangiocarcinoma using diagnostic urine tests. Read more
HBF Happenings
May is Hepatitis Awareness Month!
Get involved and find an activity near you to promote hepatitis B awareness and education on the HBF website.
Download the HBF's 3-Part Liver Cancer Webinar Series
to Learn More
Visit our dedicated patient-focused liver cancer website to access the free webinars at www.livercancerconnect.org.
Justice Department Settles with New Jersey Medical Schools Over HBV-Related Discrimination
Page last modified May 13, 2013
